| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
52,775,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,247,701 |
Avg
Vol: |
599,363 |
| 52
Week Range: |
$10.49 - $10.49 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kruka William C. |
Sr VP Corporate Development |
• – – |
2010-03-16 |
4 |
D |
$3.65 |
$10,041 |
D/D |
(2,751) |
69,443 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2010-03-16 |
4 |
D |
$3.65 |
$6,760 |
D/D |
(1,852) |
108,893 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2010-03-16 |
4 |
D |
$3.65 |
$6,760 |
D/D |
(1,852) |
65,277 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2010-03-16 |
4 |
D |
$3.65 |
$10,041 |
D/D |
(2,751) |
66,910 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2010-03-08 |
4 |
D |
$3.68 |
$5,259 |
D/D |
(1,429) |
104,912 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2010-03-08 |
4 |
D |
$3.68 |
$11,684 |
D/D |
(3,175) |
495,722 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2010-03-08 |
4 |
D |
$3.68 |
$5,259 |
D/D |
(1,429) |
515,017 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2010-03-08 |
4 |
D |
$3.68 |
$6,076 |
D/D |
(1,651) |
64,694 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2010-03-08 |
4 |
D |
$3.68 |
$4,968 |
D/D |
(1,350) |
61,296 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2010-03-08 |
4 |
D |
$3.68 |
$6,076 |
D/D |
(1,651) |
62,161 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2010-03-03 |
4 |
D |
$3.68 |
$286,385 |
D/D |
(77,822) |
446,241 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2010-03-03 |
4 |
D |
$3.68 |
$43,645 |
D/D |
(11,860) |
51,827 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2010-03-03 |
4 |
D |
$3.68 |
$58,615 |
D/D |
(15,928) |
52,268 |
|
- |
|
| Griffith Joseph H. Iv |
VP, Finance & Controller |
• – – |
2010-03-03 |
4 |
D |
$3.68 |
$21,267 |
D/D |
(5,779) |
21,631 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2010-03-03 |
4 |
D |
$3.68 |
$58,140 |
D/D |
(15,799) |
504,354 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2010-03-03 |
4 |
D |
$3.68 |
$58,983 |
D/D |
(16,028) |
54,801 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2010-03-03 |
4 |
D |
$3.68 |
$44,469 |
D/D |
(12,084) |
95,272 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2010-02-27 |
4 |
D |
$3.63 |
$5,169 |
D/D |
(1,424) |
78,946 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2010-02-27 |
4 |
D |
$3.63 |
$2,755 |
D/D |
(759) |
36,253 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2010-02-27 |
4 |
D |
$3.63 |
$4,135 |
D/D |
(1,139) |
480,722 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2009-11-16 |
4 |
D |
$2.64 |
$4,192 |
D/D |
(1,588) |
478,861 |
|
- |
|
| Griffith Joseph H. Iv |
VP, Finance & Controller |
• – – |
2009-09-22 |
4 |
D |
$2.25 |
$257 |
D/D |
(114) |
12,867 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2009-08-17 |
4 |
D |
$1.85 |
$734 |
D/D |
(397) |
35,012 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2009-08-17 |
4 |
D |
$1.85 |
$1,985 |
D/D |
(1,073) |
31,479 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2009-08-17 |
4 |
D |
$1.85 |
$2,233 |
D/D |
(1,207) |
32,436 |
|
- |
|
291 Records found
|
|
Page 5 of 12 |
|
|
